How Bayer Lost Its Monopoly: The Story Behind India’s First Compulsory License

The legal dispute between Bayer Corporation and the Union of India, along with other parties, centered on India’s first compulsory license for the anticancer drug Sorafenib (marketed as Nexavar). The Intellectual Property Appellate Board (IPAB) thus upheld the license and concluded Bayer had failed to ensure public access to the drug at an affordable price. […]

Licensing in the UAE

The Federal Law of the UAE No. 17 of 2002, in the Regulation and protection of industrial property for patents and industrial designs in Article 1 clearly depicts the intent of the invention for which the patent is granted and indicated the same article specifies what is meant by a patent. It is clear that […]

Compulsory Licensing Under The Patents Act

Under the pre-2004 provisions of the Patents Act, section 55 of the Patents Act provided that an application may be made to court for the grant of a license after 3 years from the date of the grant of a patent, or 4 years from the date of filing of the patent application, whichever is […]